Allurion Technologies Inc. (NYSE:ALUR – Get Free Report) was the target of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 125,700 shares, a drop of 34.0% from the February 13th total of 190,500 shares. Based on an average daily volume of 1,400,000 shares, the short-interest ratio is presently 0.1 days. Currently, 2.5% of the company’s stock are sold short.
Allurion Technologies Stock Performance
Shares of ALUR stock traded up $0.20 during trading hours on Monday, hitting $2.58. 52,606 shares of the company were exchanged, compared to its average volume of 393,156. Allurion Technologies has a one year low of $2.15 and a one year high of $98.75. The business’s 50-day simple moving average is $4.44 and its two-hundred day simple moving average is $10.59. The stock has a market capitalization of $12.36 million, a price-to-earnings ratio of -0.21 and a beta of -0.59.
Hedge Funds Weigh In On Allurion Technologies
An institutional investor recently raised its position in Allurion Technologies stock. Geode Capital Management LLC boosted its holdings in Allurion Technologies Inc. (NYSE:ALUR – Free Report) by 40.7% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 516,330 shares of the company’s stock after acquiring an additional 149,484 shares during the period. Geode Capital Management LLC owned about 0.80% of Allurion Technologies worth $317,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 21.39% of the company’s stock.
Allurion Technologies Company Profile
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
See Also
- Five stocks we like better than Allurion Technologies
- Which Wall Street Analysts are the Most Accurate?
- Can TikTok Stock Picks Really Make You Rich?
- Most Volatile Stocks, What Investors Need to Know
- The “Quality” Rotation: Back to Basics Investing
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
